Cargando…
Atropisomeric Racemization Kinetics of MRTX1719 Using Chiral Solvating Agent-Assisted (19)F NMR Spectroscopy
[Image: see text] With renewed interest in atropisomerism of drug molecules, efficient methods to experimentally determine torsion rotational energy barriers are needed. Here, we describe use of the chiral phosphoric acid solvating agent (+)-TiPSY to resolve the signals of atropisomers in (19)F NMR...
Autores principales: | Kulyk, Svitlana, De Paul, Susan M., Marx, Matthew A., Peakman, Torren M., Smith, Christopher R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476184/ https://www.ncbi.nlm.nih.gov/pubmed/36120049 http://dx.doi.org/10.1021/acsomega.2c03316 |
Ejemplares similares
-
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer
por: Engstrom, Lars D., et al.
Publicado: (2023) -
Chiral Phosphoric Acid Promoted Chiral 1H NMR Analysis of Atropisomeric Quinolines
por: Wan, Junlin, et al.
Publicado: (2021) -
Chiral (1)H NMR of Atropisomeric Quinazolinones With Enantiopure Phosphoric Acids
por: Wu, Chaofei, et al.
Publicado: (2018) -
Renewable Resources
for Enantiodiscrimination: Chiral
Solvating Agents for NMR Spectroscopy from Isomannide and Isosorbide
por: Balzano, Federica, et al.
Publicado: (2022) -
BINOL-like atropisomeric chiral nanographene
por: Li, Shengtao, et al.
Publicado: (2023)